L26/P-013 effectiveness of physiological intracytoplasmic sperm injection (PICSI) for patients with low sperm hyaluronic acid-binding capacity
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von R. Yamaguchi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can PICSI improve treatment outcomes in the subsequent cycle after poor or failed results with conventional ICSI in patients with low hyaluronic acid-binding capacity? Summary answer PICSI reduces overall miscarriage rates and improves embryo development in patients with low sperm hyaluronic acid-binding capacity. What is known already Hyaluronic acid-based sperm selection enables the visualization and use of physiologically mature sperm for ICSI. Previous studies comparing conventional ICSI and PICSI have reported lower miscarriage rates, particularly in patients with a hyaluronic acid-binding rate (HBR) of < 65%. However, evidence linking HBR directly with embryo development remains limited, and few studies have compared ICSI and PICSI within the same patient using paired cycles. Thus, the clinical effectiveness of HA-based sperm selection remains unclear. Study design, size, duration This retrospective study was conducted at a private fertility clinic from January 2021 to September 2025. Ninety-five PICSI cycles in 95 patients were compared with each patient’s previous conventional ICSI cycle. Cases with severe male factor infertility, including severe oligozoospermia and TESE sperm, were excluded. Participants/materials, setting, methods Fertilization, day-3 good embryo, blastocyst formation, good blastocyst, usable blastocyst, pregnancy and miscarriage rates were compared between ICSI and PICSI cycles. HBR was measured using the HBA® Assay after density-gradient sperm preparation (n = 85). Following Worrilow et al. (Hum Reprod, 2013), subgroup analyses were performed for cycles with HBR <65% (n = 68) and ≥65% (n = 17). Main results and the role of chance There were no differences in male and female ages, AMH levels, cause of infertility, and induction method between the ICSI and PICSI groups. Fertilization rates and day-3 good embryo rates were comparable, with values of [72.6% (345/475) vs. 76.6% (399/521)] and [33.3% (91/273) vs. 30.8% (121/393)], respectively. However, the PICSI group showed significantly higher blastocyst rates [31.1% (85/273) vs. 44.0% (170/386)], good blastocyst rates [5.0% (15/273) vs. 13.5% (52/386)] and usable blastocyst rates [23.8% (65/273) vs. 39.9% (154/386)] (p < 0.05). Comparison of the clinical results of frozen-thawed blastocyst transfer showed that pregnancy rates were not significantly different [25.0% (10/40) vs. 41.2% (21/51)], whereas miscarriage rates were significantly lower with PICSI [70.0% (7/10) vs. 14.3% (3/21)]. In the HBR <65% subgroup, fertilization rates remained similar [73.4% (257/350) vs. 75.7% (290/383)], while PICSI significantly improved blastocyst formation [32.7% (67/205) vs. 43.0% (123/286)], good blastocyst rates [4.9% (10/205) vs. 15.0% (43/286)] and usable blastocyst rates [23.4% (48/205) vs. 32.5% (93/286)] (p < 0.05). No significant differences were observed in the HBR ≥65% subgroup. Limitations, reasons for caution Given the uneven distribution of HBR values in our cohort, an optimal threshold for predicting PICSI benefit requires further validation. In addition, the number of cases with pregnancy outcomes was limited, indicating a need for further investigation. Wider implications of the findings PICSI appears particularly beneficial when HBR <65%, likely because it enhances the selection of sperm expressing HspA2 and other HA-binding proteins associated with nuclear maturity. Such sperm exhibit lower DNA damage, which may contribute to improved embryo development and reduced miscarriage rates. Trial registration number No
Zitieren
APA
Yamaguchi, R., Hattori, H., Kasahara, Y., Toya, M., & Kyono, K. (2026). L26/P-013 effectiveness of physiological intracytoplasmic sperm injection (PICSI) for patients with low sperm hyaluronic acid-binding capacity. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.349
Vancouver
Yamaguchi R, Hattori H, Kasahara Y, Toya M, Kyono K. L26/P-013 effectiveness of physiological intracytoplasmic sperm injection (PICSI) for patients with low sperm hyaluronic acid-binding capacity. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.349
BibTeX
@article{Yamaguchi2026,
author = {Yamaguchi, R. and Hattori, H. and Kasahara, Y. and Toya, M. and Kyono, K.},
title = {L26/P-013 effectiveness of physiological intracytoplasmic sperm injection (PICSI) for patients with low sperm hyaluronic acid-binding capacity},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.349}
}
EUVIMED